Multiple signaling pathways have been shown to regulate increased glutamine utilization in a variety of disease contexts.15,31, , , –35 Of the possible candidate pathways, the pathway with the greatest relevance to PAH that also potently regulates glutamine metabolism is hypoxia-inducible factor 1-alpha (HIF1α). The gene discussed is HIF1A; the disease is pulmonary arterial hypertension.